Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: The effect and problems

Clinical Cancer Research

Volumn 11, Issue 21, 2005, Pages 7953-7957

  Chang, Mei Hwei ^a   Chen, Tony Hsiu Hsi ^b   Hsu, Hsu Mei ^c   Wu, Tzee Chung ^d   Kong, Man Shan ^f   Liang, Der Cherng ^e   Ni, Yen Hsuan ^a   Chen, Chien Jen ^b   Chen, Ding Shinn ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

^f CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; VIRUS DNA;

ADOLESCENT; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER REGISTRY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SEROEPIDEMIOLOGY; TAIWAN; TREATMENT FAILURE; VACCINATION; VERTICAL TRANSMISSION;

ADOLESCENT; CARCINOMA, HEPATOCELLULAR; CHILD; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION; IMMUNOGLOBULINS; LIVER NEOPLASMS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REGISTRIES; REGRESSION ANALYSIS; RISK; TAIWAN; TIME FACTORS; VACCINATION;

EID: 27744549862     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-1095     Document Type: Article

References (20)

1. Larouze B, Saimot G, Lustbader ED, et al. Host response to hepatitis B infection in patients with primary hepatic carcinoma and their families: a case control study in Senegal, West Africa. Lancet 1976;2:534-8.
2. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129-33.
3. Popper H, Gerber MA, Thung SN. The relation of hepatocellular carcinoma to infection with hepatitis B and related viruses in man and animals. Hepatology 1982;2(Suppl):1-9S.
4. Ryder RW, Whittle HC, Sanneh ABK, et al. Persistent hepatitis B virus infection and hepatoma in the Gambia, West Africa. Am J Epidemiol 1992;136:1122-31.
5. Chen DS. Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In: Okuda K, Ishak G, editors. Neoplasms of the liver. Tokyo: Springer-Verlag; 1987. p. 71-80.
6. Chang MH, Chen DS, Hsu HC, et al. Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 1989;64:2377-80.
7. Chang MH, Lee CY, Chen DS. Minimal role of hepatitis C virus infection in childhood liver diseases in an area hyperendemic for hepatitis B infection. J Med Virol 1993;40:322-5.
8. Ni YH, Chang MH, Huang LM, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after universal hepatitis B vaccination. Ann Intern Med 2001;135:769-800.
9. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336:1855-9.
10. Ni YH, Chang MH, Hsu HY, et al. Hepatocellular carcinoma in childhood: clinical manifestations and prognosis. Cancer 1991;68:1737-41.
11. Kuo CY, Liu HC, Chang MH, et al. Hepatoblastoma in infancy and childhood: a clinical and pathological study of 32 cases. Acta Paediatr Taiwan 1991;32:79-87.
12. Chen DS, Hsu NH, Sung JL, et al. Mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987;257:2597-603.
13. Hsu HY, Chang MH, Chen DS, et al. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18:301-7.
14. Tsen YJ, Chang MH, Hsu HY, et al. Seroepidemiology of hepatitis B virus infection in Taipei, 1989, five years after a mass hepatitis B vaccination program. J Med Virol 1991;34:96-9.
15. Chen HL, Chang MH, Hsu HY, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996;276:906-8.
16. Hsu HM, Lu CF, Lee SC, et al. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 1999;179:367-70.
17. Breslow NF, Day NE. Statistical methods in cancer research II: the design and analysis of cohort studies. In: Breslow NF, Day NE, editors. Fitting models to group data. IARC Scientific Publication No.2. Lyon (France): IARC: 1987. p. 121-76.
18. Stevens CE, Beasley RP, Tsui J, et al. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-4.
19. Tang JR, Hsu HY, Lin HH, et al. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr 1998;133:374-7.
20. van Zonneveld M, van Nunen AB, Niesters HGM, et al. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003;10:294-7.